TradingKey

關於 Madrigal Pharmaceuticals Inc 公司

公司簡介

公司代碼MDGL

公司名稱Madrigal Pharmaceuticals Inc

上市日期Feb 06, 2007

CEOMr. Bill Sibold

員工數量528

證券類型Ordinary Share

年結日Feb 06

公司地址200 Barr Harbor Dr Ste 400

城市WEST CONSHOHOCKEN

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編19428-2978

電話14043809263

網址https://www.madrigalpharma.com/

公司代碼MDGL

上市日期Feb 06, 2007

CEOMr. Bill Sibold

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Rebecca A. Taub, M.D.

Director

442.32K

--

Dr. Paul A. Friedman, M.D.

Director

165.12K

--

Dr. Richard S. Levy, M.D.

Independent Director

11.38K

+6.70%

Dr. David Soergel, M.D.

Executive Vice President, Chief Medical Officer

7.54K

--

Mr. Raymond Cheong, M.D., Ph.D.

Independent Director

2.40K

--

Mr. Kenneth M. (Ken) Bate

Independent Director

1.91K

--

Ms. Shannon Kelley

Executive Vice President, Chief Legal Counsel

--

-100.00%

Mr. James M. Daly

Independent Director

--

Dr. Jacqualyn (Jackie) Fouse, Ph.D.

Independent Director

--

Mr. Julian C. Baker

Independent Chairman of the Board

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Rebecca A. Taub, M.D.

Director

442.32K

--

Dr. Paul A. Friedman, M.D.

Director

165.12K

--

Dr. Richard S. Levy, M.D.

Independent Director

11.38K

+6.70%

Dr. David Soergel, M.D.

Executive Vice President, Chief Medical Officer

7.54K

--

Mr. Raymond Cheong, M.D., Ph.D.

Independent Director

2.40K

--

Mr. Kenneth M. (Ken) Bate

Independent Director

1.91K

--

收入明細

暫無數據

暫無數據

業務

地區

暫無數據

股東統計

更新時間: 8月16日週六

持股股東

股東類型

持股股東

佔比

Janus Henderson Investors

9.83%

Baker Bros. Advisors LP

9.61%

Paulson & Co. Inc.

9.37%

RTW Investments L.P.

8.94%

Avoro Capital Advisors LLC

8.41%

其他

53.83%

持股股東

佔比

Janus Henderson Investors

9.83%

Baker Bros. Advisors LP

9.61%

Paulson & Co. Inc.

9.37%

RTW Investments L.P.

8.94%

Avoro Capital Advisors LLC

8.41%

其他

53.83%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

43.16%

Investment Advisor

33.27%

Hedge Fund

17.09%

Family Office

9.38%

Individual Investor

4.76%

Corporation

2.94%

Research Firm

2.40%

Sovereign Wealth Fund

0.79%

Pension Fund

0.65%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

650

23.67M

106.20%

-1.56M

2025Q1

668

23.83M

107.57%

-1.54M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Janus Henderson Investors

2.21M

9.93%

-2.54K

-0.12%

Mar 31, 2025

Baker Bros. Advisors LP

1.98M

8.91%

+2.86K

+0.14%

Jun 20, 2025

Paulson & Co. Inc.

2.10M

9.46%

+57.52K

+2.82%

Mar 31, 2025

RTW Investments L.P.

1.99M

8.98%

--

Mar 31, 2025

Avoro Capital Advisors LLC

2.02M

9.11%

-6.78K

-0.33%

Mar 31, 2025

The Vanguard Group, Inc.

1.69M

7.6%

-16.02K

-0.94%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

1.32M

5.92%

-17.10K

-1.28%

Mar 31, 2025

State Street Global Advisors (US)

758.51K

3.42%

-22.78K

-2.92%

Mar 31, 2025

SQN, L.L.C.

655.54K

2.95%

--

Apr 01, 2025

UBS Financial Services, Inc.

290.47K

1.31%

+4.09K

+1.43%

Mar 31, 2025

持股ETF

更新時間: 8月6日週三

機構名稱

佔比

Virtus LifeSci Biotech Products ETF

1.96%

SPDR S&P Biotech ETF

1.87%

Global X Guru Index ETF

1.31%

Direxion Daily S&P Biotech Bull 3X Shares

1.2%

Tema Heart & Health ETF

1%

ProShares Ultra Nasdaq Biotechnology

0.75%

Invesco Nasdaq Biotechnology ETF

0.66%

iShares Biotechnology ETF

0.62%

First Trust Innovation Leaders ETF

0.61%

FlexShares US Quality Low Volatility Index Fund

0.53%

Virtus LifeSci Biotech Products ETF

佔比1.96%

SPDR S&P Biotech ETF

佔比1.87%

Global X Guru Index ETF

佔比1.31%

Direxion Daily S&P Biotech Bull 3X Shares

佔比1.2%

Tema Heart & Health ETF

佔比1%

ProShares Ultra Nasdaq Biotechnology

佔比0.75%

Invesco Nasdaq Biotechnology ETF

佔比0.66%

iShares Biotechnology ETF

佔比0.62%

First Trust Innovation Leaders ETF

佔比0.61%

FlexShares US Quality Low Volatility Index Fund

佔比0.53%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

MDGL

437.850USD

MDGL

437.850

概覽

公司

財務

分析